Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Sun Pharmaceutical Industries

BSE: 524715|NSE: SUNPHARMA|ISIN: INE044A01036|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 12, 16:00
520.80
-7.7 (-1.46%)
VOLUME 189,291
LIVE
NSE
Dec 12, 15:59
520.85
-8.75 (-1.65%)
VOLUME 2,669,035
Announcements on Sun Pharma

30th-Nov-2017 13:53Source: BSE

Sun Pharmaceutical Industries- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Virtuous Finance Pvt Ltd

24th-Nov-2017 20:00Source: BSE

Sun Pharmaceutical Industries- Press Release / Media Release

We are pleased to enclose herewith our Press Release relating to clarification on voluntary recall of Riomet, which we shall be releasing after sending this letter to you. This is for your informatio...

22nd-Nov-2017 20:01Source: BSE

Sun Pharmaceutical Industries- Updates on Acquisition

Further to our letter dated December 23, 2016 under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding acquisition of 13,000,000 Series B Preferre...

22nd-Nov-2017 11:43Source: BSE

Sun Pharmaceutical Industries- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Valia

15th-Nov-2017 12:36Source: BSE

Sun Pharmaceutical Industries- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Valia

14th-Nov-2017 17:07Source: BSE

Sun Pharmaceutical Industries- Sun Pharma Reports Q2FY18 Results

Please find enclosed herewith our Press Release relating to second quarter & first half FY18 financials, which we shall be releasing after sending this letter to you. This is for your information and ...

14th-Nov-2017 16:18Source: BSE

Sun Pharmaceutical Industries- Outcome of Committee Meeting

This is to inform you that the Committee of Directors (Allotment) at its meeting held today i.e. on Tuesday, November 14, 2017 allotted 1,260 (One Thousand Two Hundred and Sixty) equity shares of the ...

14th-Nov-2017 16:12Source: BSE

Sun Pharmaceutical Industries- Scheme of Arrangement

Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding Scheme of Arrangement approved at Board Meeti...

14th-Nov-2017 16:10Source: NSE

Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited has informed the Exchange regarding Outcome of Board Meeting held on November 14, 2017.

14th-Nov-2017 16:05Source: NSE

Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited has submitted to the Exchange, the financial results for the period ended September 30, 2017.

1 2 3 4 5 Next >>
Quick Links for Sun Pharmaceutical Industries
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.